The method for producing highly stable reduced glutathione for injection according to claim 1, wherein: in step 5, the freeze-drying comprises the steps of, preparing liquid and filling at 20-30 , putting a sample into a freeze dryer, quickly reducing the temperature of a plate layer to-40 , preserving heat for 1h, when the temperature of a partition plate is-10 +/-2 , preserving heat for 1h, quickly reducing the temperature of the plate layer to-40 within 1h, preserving heat for 3h, transferring to a cold trap at-50 , vacuumizing to below 10Pa, firstly preserving the temperature of the plate layer at-5 for 3h, then heating the plate layer to 10 within 3h, when a product is at 0 , starting to increase the temperature of the plate layer to 40 , and when the product is increased to 30 , preserving heat for 5 h
Every powerful compound or combination comes with potential risks that must be carefully managed in a research setting
Drucker DJ, Dritselis A, Kirkpatrick P
To measure the integrity of the model, the paracellular marker sodium fluorescein (SF
FIGURE 2 3.1.1 BPTES BPTES is a specific GLS1 inhibitor that forms a stable inactive tetrameric form of KGA (Katt et al., 2012
doi: 10.1080/2162402X.2019.1633235 129 WangJ
